Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.58 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.47 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 2/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.36 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.36 |
| ▸ | CLK1 | P49759 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4985353 | 0.86 | EGFR (0.65) | EGFRPIK3CDPIK3CATDO2IMPDH2 | |
| SCHEMBL31124778 | 0.86 | EGFR (0.65) | EGFRPIK3CDPIK3CATDO2IMPDH2 | |
| Hydroquinone SCHEMBL8878778 | 0.86 | EGFR (0.52) | EGFRPIK3CDPIK3CAFGFR4TDO2 | |
| Benzoquinone SCHEMBL8874151 | 0.86 | EGFR (0.47) | EGFRPIK3CDPIK3CAFGFR4TDO2 | |
| SCHEMBL29551582 | 0.83 | EGFR (0.48) | EGFRPIK3CDPIK3CAFGFR4 | |
| SCHEMBL2190665 | 0.83 | EGFR (0.48) | EGFRPIK3CDPIK3CAFGFR4TDO2 | |
| SCHEMBL8404388 | 0.83 | EGFR (0.48) | EGFRPIK3CDPIK3CAFGFR4IMPDH2 | |
| SCHEMBL7222157 | 0.83 | EGFR (0.59) | EGFRPIK3CDPIK3CAFGFR4TDO2 | |
| SCHEMBL28181384 | 0.83 | EGFR (0.48) | EGFRPIK3CDPIK3CAFGFR4 | |
| SCHEMBL9729774 | 0.82 | CLK1 (0.61) | EGFRPIK3CDPIK3CACSNK1DCSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5639881-A | ANTITUMOR AGENTS, TREATMENT OF BREAST CANCER | ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1997-06-17 | — | — | US | claimed |
| JP-7309873-A | — | — | None | — | — | JP | disclosed |
| US-5639881-A | ANTITUMOR AGENTS, TREATMENT OF BREAST CANCER | ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1997-06-17 | — | — | US | disclosed |
| US-5639881-A | ANTITUMOR AGENTS, TREATMENT OF BREAST CANCER | ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1997-06-17 | — | — | US | disclosed |
| JP-H07309873-A | PYRIMIDO(4,5-G)QUINAZOLINE DERIVATIVE | UNIV ARIZONA FOUND | 1995-11-28 | — | — | JP | disclosed |
| EP-0541404-A2 | Pyrimido(4,5-g)quinazoline derivatives with anti-tumour activity | ARIZONA BOARD OF REGENTS (US) | 1993-05-12 | — | — | EP | disclosed |
| EP-0541404-A2 | Pyrimido(4,5-g)quinazoline derivatives with anti-tumour activity | ARIZONA BOARD OF REGENTS (US) | 1993-05-12 | — | — | EP | disclosed |